EGFR c.168T>A ;(p.N56K)

Variant ID: 7-55210058-T-A

NM_005228.3(EGFR):c.168T>A;(p.N56K)

This variant was identified in 8 publications

View GRCh38 version.




Publications:


Engaging innate immunity for targeting the epidermal growth factor receptor: Therapeutic options leveraging innate immunity versus adaptive immunity versus inhibition of signaling.

Frontiers In Oncology
Hintzen, Gabriele G; Dulat, Holger J HJ; Rajkovic, Erich E
Publication Date: 2022

Variant appearance in text: EGFR: N56K
PubMed Link: 36185288
Variant Present in the following documents:
  • Main text
  • fonc-12-892212.pdf
View BVdb publication page



EGFR Mutations in Head and Neck Squamous Cell Carcinoma.

International Journal Of Molecular Sciences
Nair, Sindhu S; Bonner, James A JA; Bredel, Markus M
Publication Date: 2022-03-30

Variant appearance in text: EGFR: N56K
PubMed Link: 35409179
Variant Present in the following documents:
  • Main text
  • ijms-23-03818.pdf
View BVdb publication page



Precision Medicine Approaches to Overcome Resistance to Therapy in Head and Neck Cancers.

Frontiers In Oncology
Ortiz-Cuaran, Sandra S; Bouaoud, Jebrane J; Karabajakian, Andy A; Fayette, Jérôme J; Saintigny, Pierre P
Publication Date: 2021

Variant appearance in text: EGFR: N56K
PubMed Link: 33718169
Variant Present in the following documents:
  • Main text
View BVdb publication page



Covalent N-arylation by the pollutant 1,2-naphthoquinone activates the EGF receptor.

The Journal Of Biological Chemistry
Nakahara, Kengo K; Hamada, Kyohei K; Tsuchida, Tomoki T; Takasugi, Nobumasa N; Abiko, Yumi Y; Shien, Kazuhiko K; Toyooka, Shinichi S; Kumagai, Yoshito Y; Uehara, Takashi T
Publication Date: 2021

Variant appearance in text: EGFR: N56K
PubMed Link: 33705793
Variant Present in the following documents:
  • Main text
  • main.pdf
View BVdb publication page



Novel EGFR ectodomain mutations associated with ligand-independent activation and cetuximab resistance in head and neck cancer.

Plos One
Nair, Sindhu S; Trummell, Hoa Q HQ; Rajbhandari, Rajani R; Thudi, Nanda K NK; Nozell, Susan E SE; Warram, Jason M JM; Willey, Christopher D CD; Yang, Eddy S ES; Placzek, William J WJ; Bonner, James A JA; Bredel, Markus M
Publication Date: 2020

Variant appearance in text: EGFR: N56K
PubMed Link: 32069320
Variant Present in the following documents:
  • Main text
  • pone.0229077.pdf
View BVdb publication page



Kinome-wide decoding of network-attacking mutations rewiring cancer signaling.

Cell
Creixell, Pau P; Schoof, Erwin M EM; Simpson, Craig D CD; Longden, James J; Miller, Chad J CJ; Lou, Hua Jane HJ; Perryman, Lara L; Cox, Thomas R TR; Zivanovic, Nevena N; Palmeri, Antonio A; Wesolowska-Andersen, Agata A; Helmer-Citterich, Manuela M; Ferkinghoff-Borg, Jesper J; Itamochi, Hiroaki H; Bodenmiller, Bernd B; Erler, Janine T JT; Turk, Benjamin E BE; Linding, Rune R
Publication Date: 2015-09-24

Variant appearance in text: EGFR: N56K
PubMed Link: 26388441
Variant Present in the following documents:
  • mmc4.xlsx, sheet 1
View BVdb publication page



Fibroblast growth factor signaling and inhibition in non-small cell lung cancer and their role in squamous cell tumors.

Cancer Medicine
Salgia, Ravi R
Publication Date: 2014-06

Variant appearance in text: EGFR: N56K
PubMed Link: 24711160
Variant Present in the following documents:
  • Main text
  • cam40003-0681.pdf
View BVdb publication page